Image

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

Study of Investigational Medication for Solid Tumors

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates solid tumors. It looks at how safe and tolerable the investigational medication is for people with these tumors.

The study evaluates how the investigational medication works in the body, including its safety and effectiveness. It also looks at imaging properties to see how well the medication can be tracked inside the body.

  • Who can participate: Adults aged 18 and older with certain types of breast and lung cancers that are locally advanced or metastatic may participate. Participants must show uptake in imaging scans.
  • Study details: Participants will receive the investigational medication, which is being studied for its effects on solid tumors.
Print
Study details
    Pancreatic Ductal Adenocarcinoma
    Non-Small Cell Lung Cancer
    HR+/HER2- Ductal and Lobular Breast Cancer
    Triple Negative Breast Cancer
    Colorectal Cancer
    Soft Tissue Sarcoma

NCT07261631

Novartis Pharmaceuticals

17 October 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.